Knoll Capital Management, LLC Ocuphire Pharma, Inc. Transaction History
Knoll Capital Management, LLC
- $148 Million
- Q2 2024
A detailed history of Knoll Capital Management, LLC transactions in Ocuphire Pharma, Inc. stock. As of the latest transaction made, Knoll Capital Management, LLC holds 100,000 shares of OCUP stock, worth $118,000. This represents 0.1% of its overall portfolio holdings.
Number of Shares
100,000
Previous 100,000
-0.0%
Holding current value
$118,000
Previous $200,000
23.5%
% of portfolio
0.1%
Previous 0.12%
Shares
1 transactions
Others Institutions Holding OCUP
# of Institutions
44Shares Held
2.54MCall Options Held
2KPut Options Held
2K-
Vanguard Group Inc Valley Forge, PA992KShares$1.17 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA266KShares$313,7070.0% of portfolio
-
Richmond Brothers, Inc. Jackson, MI191KShares$225,7380.6% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX164KShares$193,2140.01% of portfolio
-
Black Rock Inc. New York, NY107KShares$126,1830.0% of portfolio
About Ocuphire Pharma, Inc.
- Ticker OCUP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,579,800
- Market Cap $24.3M
- Description
- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...